Low-grade glioma is a tumor type that affects the central nervous system, with favorable survival outcomes in children and adolescents. A study now provides insights into long-term mortality and morbidity associated with different treatments and demonstrates the multifaceted outcomes of adult survivors of childhood glioma.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ostrom, Q. T. et al. Neuro. Oncol. 16(suppl .1), x1–x36 (2015).
Krishnatry, R. et al. Cancer 122, 1261–1269 (2016).
Gnekow, A. K. et al. Neuro. Oncol. 14, 1265–1284 (2012).
de Blank, P. M. K. et al. Nat. Cancer https://doi.org/10.1038/s43018-024-00733-0 (2024).
Merchant, T. E., Conklin, H. M., Wu, S., Lustig, R. H. & Xiong, X. J. Clin. Oncol. 27, 3691–3697 (2009).
Williams, N. L. et al. Am. J. Clin. Oncol. Cancer Clin. Trials 41, 307–312 (2018).
Traunwieser, T. et al. Neuro-Oncol. Adv. 2, vdaa094 (2020).
Yamanaka, R., Hayano, A. & Kanayama, T. Neurosurg.l Rev. 41, 719–731 (2018).
Ajithkumar, T., Taylor, R. & Kortmann, R. D. Clin. Oncol. 31, 151–161 (2019).
Ryall, S. et al. Cancer Cell 37, 569–583.e5 (2020).
Miklja, Z. et al. Neuro. Oncol. 21, 968–980 (2019).
Hargrave, D. R. et al. Clin. Cancer Res. 25, 7303–7311 (2019).
Bouffet, E. et al. N. Engl. J. Med. 389, 1108–1120 (2023).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
M.P. has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals, Janssen, Servier, Miltenyi, Böhringer-Ingelheim, Telix and Medscape. J.G. has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Novartis and Roche.
Rights and permissions
About this article
Cite this article
Gojo, J., Preusser, M. Improving long-term outcomes in pediatric low-grade glioma. Nat Cancer 5, 533–535 (2024). https://doi.org/10.1038/s43018-024-00741-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-024-00741-0